Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Todd Neale

January 29, 2026

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

Caitlin E. Cox

March 31, 2022

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

High-Normal Glucose Challenge Tests in Pregnancy May Predict Future Risk of CV Events

L.A. McKeown

April 11, 2019

Advertisement

AHA/ASA Release New Comprehensive Acute Ischemic Stroke Guideline

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

High-Normal Glucose Challenge Tests in Pregnancy May Predict Future Risk of CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content